zutectra - search results

Singapore - English - HSA (Health Sciences Authority)

atectura breezhaler inhalation powder hard capsule 150 mcg 80 mcg

novartis (singapore) pte ltd - indacaterol acetate equivalent to indacaterol; mometasone furoate - powder, metered - indacaterol acetate equivalent to indacaterol 150 mcg; mometasone furoate 80 mcg

New Zealand - English - Medsafe (Medicines Safety Authority)

atectura breezhaler

novartis new zealand ltd - indacaterol acetate 173ug equivalent to indacaterol 150µg; mometasone furoate 160ug - powder filled inhalation capsule - active: indacaterol acetate 173ug equivalent to indacaterol 150µg mometasone furoate 160ug excipient: gelatin printing ink, grey lactose monohydrate - atectura breezhaler is indicated as a once-daily maintenance treatment of asthma in adults and adolescents 12 years of age and older where use of a combination of long-acting beta2-agonist and inhaled corticosteroid is appropriate: · patients not adequately controlled with inhaled corticosteroids and "as needed" inhaled short-acting beta2-agonists or · patients not adequately controlled with long-acting beta2-agonists and low dose of inhaled corticosteroids and "as needed" inhaled short-acting beta2-agonists.

New Zealand - English - Medsafe (Medicines Safety Authority)

atectura breezhaler

novartis new zealand ltd - indacaterol acetate 173ug equivalent to indacaterol 150µg; mometasone furoate 320ug - powder filled inhalation capsule - active: indacaterol acetate 173ug equivalent to indacaterol 150µg mometasone furoate 320ug excipient: gelatin printing ink, black lactose monohydrate - atectura breezhaler is indicated as a once-daily maintenance treatment of asthma in adults and adolescents 12 years of age and older where use of a combination of long-acting beta2-agonist and inhaled corticosteroid is appropriate: · patients not adequately controlled with inhaled corticosteroids and "as needed" inhaled short-acting beta2-agonists or · patients not adequately controlled with long-acting beta2-agonists and low dose of inhaled corticosteroids and "as needed" inhaled short-acting beta2-agonists.

New Zealand - English - Medsafe (Medicines Safety Authority)

atectura breezhaler

novartis new zealand ltd - indacaterol acetate 173ug equivalent to indacaterol 150 µg; mometasone furoate 80ug - powder filled inhalation capsule - active: indacaterol acetate 173ug equivalent to indacaterol 150 µg mometasone furoate 80ug excipient: gelatin printing ink, blue lactose monohydrate - atectura breezhaler is indicated as a once-daily maintenance treatment of asthma in adults and adolescents 12 years of age and older where use of a combination of long-acting beta2-agonist and inhaled corticosteroid is appropriate: · patients not adequately controlled with inhaled corticosteroids and "as needed" inhaled short-acting beta2-agonists or · patients not adequately controlled with long-acting beta2-agonists and low dose of inhaled corticosteroids and "as needed" inhaled short-acting beta2-agonists.

European Union - English - EMA (European Medicines Agency)

nexgard spectra

boehringer ingelheim vetmedica gmbh - afoxolaner, milbemycin oxime - endectocides, antiparasitic products, insecticides and repellents, milbemycin oxime, combinations - dogs - for the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease (dirofilaria immitis larvae), angiostrongylosis (reduction in level of immature adults (l5) and adults of angiostrongylus vasorum), thelaziosis (adult thelazia callipaeda) and/or treatment of gastrointestinal nematode infestations is indicated.treatment of flea infestations (ctenocephalides felis and c. canis) in dogs for 5 weeks. treatment of tick infestations (dermacentor reticulatus, ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus) in dogs for 4 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (toxocara canis and toxascaris leonina), hookworms (ancylostoma caninum, ancylostoma braziliense and ancylostoma ceylanicum) and whipworm (trichuris vulpis). treatment of demodicosis (caused by demodex canis). treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis). prevention of heartworm disease (dirofilaria immitis larvae) with monthly administration. prevention of angiostrongylosis (by reduction of the level of infection with immature adult (l5) and adult stages of angiostrongylus vasorum) with monthly administration.prevention of establishment of thelaziosis (adult thelazia callipaeda eyeworm infection) with monthly administration.